This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Welsh Statutory Instruments
National Health Service, Wales
Made
at 12.59 p.m. on 10 December 2024
Laid before Senedd Cymru
at 5.45 p.m. on 10 December 2024
Coming into force
31 December 2024
The Welsh Ministers, in exercise of the powers conferred on them by sections 15, 80, 104 and 203(9) and (10) of the National Health Service (Wales) Act 2006(1), make the following Regulations.
1. The title of these Regulations is the National Health Service (Pharmaceutical Services) (Wales) (Amendment) (Amendment) Regulations 2024 and they come into force on 31 December 2024.
2. In the National Health Service (Pharmaceutical Services) (Wales) (Amendment) Regulations 2024(2), for regulation 1(3) substitute—
“(3) This regulation and regulation 3(5) come into force on 1 January 2025.”
Jeremy Miles
Cabinet Secretary for Health and Social Care, one of the Welsh Ministers
At 12.59 p.m. on 10 December 2024
(This note is not part of the Regulations)
These Regulations substitute a new regulation 1(3) into the National Health Service (Pharmaceutical Services) (Wales) (Amendment) Regulations 2024.
The Welsh Ministers’ Code of Practice on the carrying out of Regulatory Impact Assessments was considered in relation to these Regulations. As a result, a regulatory impact assessment has not been prepared as to the likely costs and benefits of complying with these Regulations.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
